TLSA
Tiziana Life Sciences LtdNASDAQHealthcare$1.25+2.40%ClosedMarket Cap: $74.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.31
P/S
0.00
EV/EBITDA
2.33
DCF Value
$0.05
FCF Yield
—
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-125.8%
ROA
-37.0%
ROIC
-41.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $0.00 | -Infinity% | $-9.0M | $-5.6M | $-0.10 | — |
| Q4 2024 | $0.00 | -Infinity% | $-9.2M | $-7.2M | $-0.13 | — |
| FY 2024 | $0.00 | NaN% | $-15.8M | $-11.9M | $-0.22 | — |
| Q2 2024 | $0.00 | -Infinity% | $-12.9M | $-9.3M | $-0.18 | — |
| Q4 2023 | $0.00 | -Infinity% | $-6.2M | $-9.1M | $-0.18 | — |
| FY 2023 | $0.00 | NaN% | $-18.0M | $-17.7M | $-0.34 | — |
| Q2 2023 | $0.00 | Infinity% | $-11.8M | $-8.6M | $-0.16 | — |
| Q4 2022 | $0.00 | -Infinity% | $-10.0M | $-10.9M | $-0.22 | — |
| FY 2022 | $0.00 | NaN% | $-14.6M | $-15.4M | $-0.30 | — |
| Q2 2022 | $0.00 | Infinity% | $-4.5M | $-4.5M | $-0.08 | — |
| FY 2021 | $0.00 | NaN% | $-27.4M | $-23.4M | $-0.48 | — |
| FY 2020 | $0.00 | NaN% | $-28.0M | $-26.1M | $-0.54 | — |